Literature DB >> 7600825

Combined measurements of blood lactate concentrations and gastric intramucosal pH in patients with severe sepsis.

G Friedman1, G Berlot, R J Kahn, J L Vincent.   

Abstract

OBJECTIVE: To compare the prognostic value of blood lactate concentrations, gastric intramucosal pH, and their combination in patients with severe sepsis.
DESIGN: Prospective, noninterventional study.
SETTING: Medical/surgical intensive care unit of a university hospital. PATIENTS: The study included 35 consecutive patients (44 to 82 yrs) with severe sepsis as defined by fever or hypothermia (rectal temperature > 38.3 degrees or < 35.5 degrees C), tachycardia (heart rate > 100 beats/min), tachypnea (respiratory rate > 20 breaths/min) or mechanical ventilation, abnormal white blood cell count (> 10 or < 6 x 10(3) cells/mm3), hypotension (systolic arterial pressure < 90 mm Hg), and evidence of organ dysfunction (oliguria or deterioration of mental status).
INTERVENTIONS: Arterial lactate concentration and intramucosal pH were measured at the time of study entry, and at 4 and 24 hrs later. Hemodynamic data and oxygen-derived variables were determined at the time of study entry and 24 hrs later. Arterial blood and balloon saline gases were also determined to obtain the pH gap (arterial pH-intramucosal pH) and the PCO2 gap (intramural PCO2-PaCO2).
MEASUREMENTS AND MAIN RESULTS: Of the 35 patients, 19 survived the intensive care unit stay. At the time of study admission, 23 (66%) patients had an increased lactate concentration (> 2 mEq/L) and 26 (74%) had a low intramucosal pH (< 7.32). Initially, there were no significant differences in blood lactate concentrations between nonsurvivors and survivors (3.2 +/- 1.5 vs. 2.8 +/- 2.3 mEq/L). Lactate concentrations remained high in nonsurvivors and progressively decreased in survivors (4 hrs: 3.3 +/- 1.1 mEq/L in nonsurvivors vs. 2.2 +/- 0.9 mEq/L in survivors [p < .01]; 24 hrs: 3.5 +/- 2.0 mEq/L in nonsurvivors vs. 1.9 +/- 1.1 mEq/L in survivors [p < .05]). Intramucosal pH was lower in the nonsurvivors than in the survivors initially (7.19 +/- 0.15 in nonsurvivors vs. 7.30 +/- 0.14 in survivors [p < .05]), at 4 hrs (7.18 +/- 0.17 in nonsurvivors vs. 7.29 +/- 0.13 in survivors [p = .06]), and at 24 hrs (7.19 +/- 0.31 in nonsurvivors vs. 7.30 +/- 0.17 in survivors [p < .05]). Of the 23 patients with initially high lactate concentrations, 12 (60%) of the 20 patients with low intramucosal pH died, as compared with one (33%) of the three patients with normal intramucosal pH (p = .052). Of the 14 patients with persistently high lactate concentrations at 24 hrs, all nine (100%) patients with low intramucosal pH, but only two (40%) of five patients with normal intramucosal pH died (p < .001). No significant relationship was found between lactate or intramucosal pH and oxygen-derived variables. Intramucosal pH correlated better with gastric intramural PCO2 (r2 = .58) than with arterial bicarbonate or base deficit/excess. Intramural PCO2 was a more specific predictor of mortality than intramucosal pH. When compared with patients with normal lactate concentrations, those patients with high lactate concentrations had a higher pH gap (0.22 +/- 0.22 vs. 0.07 +/- 0.13 [p < .01]) and PCO2 gap [21.0 +/- 33.9 vs. 1.8 +/- 9.8 torr [2.79 +/- 4.5 vs. 0.24 +/- 1.34 kPa]; p < .01).
CONCLUSIONS: Both lactate concentrations and intramucosal pH represent reliable prognostic indicators in severe sepsis, and their combination improves the prognostic assessment in these patients. Both variables are better prognostic indicators than oxygen-derived variables. Intramural PCO2 appears to be a more specific variable than intramucosal pH, which partially reflects systemic metabolic acidosis. Combined determinations of blood lactate concentrations and intramucosal pH or intramural PCO2 may help to predict outcome from severe sepsis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7600825     DOI: 10.1097/00003246-199507000-00006

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  30 in total

1.  Is there a place for prostacyclin in the treatment of septic shock?

Authors:  D De Backer
Journal:  Intensive Care Med       Date:  2001-07       Impact factor: 17.440

Review 2.  The adrenergic coin: perfusion and metabolism.

Authors:  Karl Träger; Peter Radermacher; Xavier Leverve
Journal:  Intensive Care Med       Date:  2002-12-19       Impact factor: 17.440

Review 3.  Monitoring CO2 in shock states.

Authors:  Pierre-Eric Danin; Nils Siegenthaler; Jacques Levraut; Gilles Bernardin; Jean Dellamonica; Karim Bendjelid
Journal:  J Clin Monit Comput       Date:  2014-11-13       Impact factor: 2.502

4.  Activation of the L-arginine nitric oxide pathway in severe sepsis.

Authors:  T Duke; M South; A Stewart
Journal:  Arch Dis Child       Date:  1997-03       Impact factor: 3.791

Review 5.  Permissive hypercapnia--role in protective lung ventilatory strategies.

Authors:  John G Laffey; Donall O'Croinin; Paul McLoughlin; Brian P Kavanagh
Journal:  Intensive Care Med       Date:  2004-01-14       Impact factor: 17.440

6.  End-points of resuscitation: arterial blood pressure, oxygen delivery, blood lactate, or...?

Authors:  J L Vincent
Journal:  Intensive Care Med       Date:  1996-01       Impact factor: 17.440

Review 7.  Monitoring the hepato-splanchnic region in the critically ill patient. Measurement techniques and clinical relevance.

Authors:  A Brinkmann; E Calzia; K Träger; P Radermacher
Journal:  Intensive Care Med       Date:  1998-06       Impact factor: 17.440

Review 8.  Monitoring tissue perfusion.

Authors:  J L Vincent
Journal:  Can J Anaesth       Date:  1996-05       Impact factor: 5.063

9.  Caecal ligation and puncture in the rat mimics the pathophysiological changes in human sepsis and causes multi-organ dysfunction.

Authors:  H F Brooks; C K Osabutey; R F Moss; P L R Andrews; D C Davies
Journal:  Metab Brain Dis       Date:  2007-12       Impact factor: 3.584

10.  Gastric tonometry versus cardiac index as resuscitation goals in septic shock: a multicenter, randomized, controlled trial.

Authors:  Fernando Palizas; Arnaldo Dubin; Tomas Regueira; Alejandro Bruhn; Elias Knobel; Silvio Lazzeri; Natalio Baredes; Glenn Hernández
Journal:  Crit Care       Date:  2009-03-31       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.